Siblings 圖書 [3/5] 期刊論文 [412/413] Collection Statistics 近3年內發表的文件:6(11.32%) 含全文筆數:49(92.45%) 文件下載次數統計 下載大於0次:49(100.00%) 下載大於100次:45(91.84%) 檔案下載總次數:18932(13.63%) 最後更新時間: 2024-12-01 01:59 Top Upload Loading... Top Download Loading... Recent Submissions MPO and trh within leukemia stem ce... Development of an artificial intell... Improving Interoperability in Healt... ILLUMINATE: Efficacy and safety of ... Association between dietary pattern... What can the anti-apoptotic molecul... Differences in gut microbiota profi... Pathogenic role of specific macroph... Nivolumab plus ipilimumab as neoadj... A phase I study of biweekly abraxan...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 26-50 of 53. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2014-02	SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder	Modern Pathology. 2014 Feb;27(Suppl. 2):245A.
2014-02	Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma	Modern Pathology. 2014 Feb;27(Suppl. 2):22A.
2014-02	CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder	Laboratory Investigation. 2014 Feb;94(S1):220A.
2014-02	SLC14A1 down-regulation is associated with poor clinical outcome in patients with urothelial carcinoma of upper urinary tracts and urinary bladder	Laboratory Investigation. 2014 Feb;94(S1):245A.
2014-02	HOXC6 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2014 Feb;94(S1):331A.
2014-02	Characterization of the clinical, biological, and therapeutic relevance of EZH2 overexpression in myxofibrosarcoma	Laboratory Investigation. 2014 Feb;94(S1):22A.
2013-10	STMN1 overexpression as a poor prognostic factor in patients with Nasopharyngeal Carcinoma	International Journal of Radiation Oncology Biology Physics. 2013 Oct;87(2, Supple. 1):S666-S667.
2013-02	GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Modern Pathology. 2013 Feb;26(Suppl. 2):230A.
2013-02	Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2013 Feb;26(Suppl. 2):308A.
2013-02	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2013 Feb;26(Suppl. 2):308A.
2013-02	Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology	Laboratory Investigation. 2013 Feb;93(Suppl. 1):14A.
2013-02	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.
2013-02	GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Laboratory Investigation. 2013 Feb;93(Suppl. 1):230A.
2013-02	Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology	Modern Pathology. 2013 Feb;26(Suppl. 2):14A.
2013-02	Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.
2011-05	Size effect on tumor treatment with PEGylated liposomal drugs in a tumor-bearing mouse model	Journal of Nuclear Medicine. 2011 May;52(Suppl. 1):Meeting Abstract 1737.
2011-04	Early Treg suppression by a Listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer	Journal of Immunology. 2011 Apr;186(Suppl. 1):Meeting Abstract 165.49.
2011-04	SOX1 functions as a tumor suppressor through antagonizing WNT/beta-catenin signaling pathway in hepatocellular carcinoma	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2199.
2009-11	Characterization of three tyrosine kinase-related gene mutations at the EGFR exons 19-21 and amplification of the EGFR gene in colorectal cancer patients	Journal of Molecular Diagnostics. 2009 Nov;11(6):654-655.
2009-07	Down-regulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome	Oral Oncology Supplement. 2009 Jul;3(1):73.
2009-05	Cellular and functional heterogeneity of the sarcomatoid renal cell carcinoma cell line RCC52 with total loss of HLA class I: A system to study mesenchymalepithelial transition	Cancer Research. 2009 May;69:Abstract number 222.
2009-05	Characterization of naturally occurring floating cells and adherent cells within the CEA-producing UP-LN1 carcinoma cell line in vitro: Identification of cancer stem cells with metastatic potential	Cancer Research. 2009 May;69:Abstract number 188.
2009-05	The basal body gene, RPGRIP1L, is a candidate tumor suppressor gene on chromosome 16q12.2 in human hepatocellular carcinoma	Cancer Research. 2009 May;69(9):Meeting Abstract 4950.
2009-05	Evaluation therapeutic efficacy of In111-VNB-liposome with dual reporter gene in human colorectal carcinoma HT-29 xenografts	Journal of Nuclear Medicine. 2009 May;50(Suppl. 2):Meeting Abstract 2306.
2009-05	Molecular imaging-based passive targeted therapeutic efficacy with pegylated liposome encapsulated with 111In and vinorelbine in colon carcinoma xenografts	Journal of Nuclear Medicine. 2009 May;50(Suppl. 2):Meeting Abstract 2303.

Showing items 26-50 of 53. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page